Laboratorios Farmaceuticos Rovi Monthly Outlook (April 2026)

Laboratorios Farmace...

BME:ROVI

€ 83,35

+ €0,90 (1,09%)

83,35 €

+€0,90 (1,09%)

End-of-day quote: 04/10/2026

Laboratorios Farmaceuticos Rovi Stock Value

Currently, analysts rate BME:ROVI as Outperform.

Outperform

Laboratorios Farmaceuticos Rovi Company Info

EPS Growth 5Y

30,33%

Market Cap

€4,26 B

Long-Term Debt

€0,08 B

Annual earnings

N/A

Dividend

€0,94

Dividend Yield

1,13%

Founded

1946

Industry

Health Care

Country

Spain

Website

Laboratorios Farmaceuticos Rovi

ISIN Number

ES0157261019

Website

http://www.rovi.es

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

€87,00

4.38%

Last Update: 04/11/2026

Analysts: 9

Highest Price Target €100,00

Average Price Target €87,00

Lowest Price Target €74,00

In the last five quarters, Laboratorios Farmaceuticos Rovi’s Price Target has fallen from €87,68 to €77,14 - a -12,02% decrease. Eight analysts predict that Laboratorios Farmaceuticos Rovi’s share price will increase in the coming year, reaching €87,00. This would represent an increase of 4,38%.

Top growth stocks in the health care sector (5Y.)

What does Laboratorios Farmaceuticos Rovi do?

Laboratorios Farmaceuticos Rovi, S.A. is a company focused on developing, manufacturing, and marketing high-quality pharmaceutical products. It holds a significant position in the pharmaceutical industry, engaging primarily in the production of active pharmaceutical ingredients and finished dosage forms. With a commitment to innovation, the company consistently invests in research and development, paving the way for new therapies that address unmet medical needs. The company's dedication to safe...

Business Segments

The company operates within several key business segments that are intricately designed to align with its strategic vision.

Pharmaceutical

The pharmaceutical segment constitutes the backbone of its operations, with a robust portfolio that includes the development and production of active pharmaceutical ingredients (APIs) and pharmaceutical formulations. This segment has seen significant growth, driven by the increasing global demand for innovative medication solutions, including biologics and advanced therapies. Additionally, the company has carved out a strong foothold in the specialty pharmaceuticals market. This segment focuses on niche therapeutic areas that require high levels of expertise and specialization.

Contract Manufacturing Services

The contract manufacturing services segment allows the company to leverage its state-of-the-art facilities and expertise in producing APIs and formulations for third-party clients. By offering flexible and scalable production capabilities, the company meets the diverse needs of its partners while optimizing production efficiency.

Business Strategy

The company's business strategy focuses on sustainable growth, innovation, and expanding its global footprint. The company underscores its commitment to research and development, prioritizing investments aimed at discovering new therapeutic solutions and enhancing existing products. By fostering a culture of innovation, the company continuously seeks to bring forth groundbreaking therapies that can significantly improve patient outcomes.

Strategically, the company aims to broaden its market presence both geographically and across therapeutic areas. The company recognizes the importance of global markets in its growth trajectory and strives to establish solid partnerships in emerging markets to tap into new customer bases.

Completing the business strategy is a focus on corporate social responsibility (CSR) and environmental sustainability. The company recognizes its obligation to operate ethically and contribute positively to society. By integrating sustainable practices within its operations, the company not only mitigates risks associated with environmental regulations but also strengthens its brand equity across diverse stakeholder groups.

Products and Services

The company offers an extensive range of products and services that demonstrate its commitment to innovation and quality. The company develops and manufactures a diverse array of active pharmaceutical ingredients (APIs), which serve as foundational components in various medications.

In addition to boasting a robust product catalog, the company provides specialized contract manufacturing services. This includes comprehensive services tailored to non-proprietary pharmaceutical companies seeking to enhance their production capabilities without the need for large capital investments in manufacturing facilities.

Geographical Markets Served

The company serves a broad range of geographical markets, reflecting its aspirations for international growth and service diversification. Its products are available across Europe, North America, Latin America, and parts of Asia.

Seasonality

The company experiences minimal seasonality in its operations. The pharmaceutical industry typically requires consistent production to meet the ongoing demand for medications, rendering seasonal fluctuations irrelevant. However, specific product launches or regulatory approvals may create minor peaks in demand, influencing production schedules. Overall, the company maintains a stable operational rhythm, characterized by its capacity to meet constant demands in the market.

Customers

The company serves a diverse clientele that includes healthcare providers, pharmacies, hospitals, and research institutions.

Sales and Marketing

The company employs a multi-channel sales and marketing strategy aimed at enhancing product visibility and generating demand. The company utilizes direct sales teams to establish relationships with healthcare providers and pharmacies, ensuring that its products are readily accessible to end consumers.

In addition to direct sales channels, the company engages in targeted marketing campaigns that leverage digital and traditional platforms. This approach enables the company to convey its value propositions effectively while educating stakeholders about its product benefits. The company also participates in industry trade shows and conferences to showcase innovations and build brand recognition within the pharmaceutical sector.

History

Laboratorios Farmaceuticos Rovi, S.A. was founded in 1946. The company was incorporated in 1946.

Laboratorios Farmaceuticos Rovi Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Pharmaceutical Products:** 75% **Heparin-based Products:** 15% **Contract Manufacturing:** 10% **Spain:** 40% **Germany:** 25% **France:** 20% Laboratorios Farmaceuticos Rovi, S.A. generates the majority of its revenue from the sale of pharmaceutical products, followed by heparin-bas...

At which locations are the company’s products manufactured?

**Production Sites:** Madrid, Spain; Granada, Spain Laboratorios Farmaceuticos Rovi, S.A. mainly produces its pharmaceutical products in Spain. The main production facilities are located in Madrid and Granada. These sites are strategically positioned for the manufacturing and development of medicat...

What strategy does Laboratorios Farmaceuticos Rovi pursue for future growth?

**Revenue Growth:** Estimated at 10-12% annually (2025 based on historical data and market trends) Laboratorios Farmaceuticos Rovi, S.A. pursues a growth strategy based on several pillars. A central component is the expansion of its production capacities, especially in the field of injectable medic...

Which raw materials are imported and from which countries?

**Main raw materials:** Pharmaceutical active ingredients, excipients, packaging materials **Countries of origin:** USA, Germany, China, India Laboratorios Farmaceuticos Rovi, S.A. mainly imports pharmaceutical active ingredients needed for the production of their medications. These active ingred...

How strong is the company’s competitive advantage?

**Market share in Europe:** approximately 5% (2024, estimated) **Research and development ratio:** 12% of revenue (2024) **EBITDA margin:** 25% (2024) Laboratorios Farmaceuticos Rovi, S.A. has established itself as a significant player in the European pharmaceutical market. The company's c...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** approximately 60% (estimated for 2025) **Insider Buys/Sells:** No significant transactions in the last quarter (estimated for 2025) The institutional investor share at Laboratorios Farmaceuticos Rovi, S.A. traditionally stands at around 60%, indicating the trust o...

What percentage market share does Laboratorios Farmaceuticos Rovi have?

**Market share of Laboratorios Farmaceuticos Rovi, S.A.:** 3.5% (2025, estimated) **Top competitors and their market shares:** 1. **Pfizer Inc.** - 15.0% 2. **Roche Holding AG** - 12.5% 3. **Novartis AG** - 11.0% 4. **Sanofi S.A.** - 9.0% 5. **GlaxoSmithKline plc** - 8.5% 6. **AstraZeneca plc** - 7...

Is Laboratorios Farmaceuticos Rovi stock currently a good investment?

**Revenue Growth:** 18% (2024) **R&D Expenses:** 12% of revenue (2024) **Market Share in Europe:** 5% (2024) Laboratorios Farmaceuticos Rovi, S.A. recorded a revenue growth of 18% in 2024, attributed to strong demand for its pharmaceutical products and successful market expansion. The company c...

Does Laboratorios Farmaceuticos Rovi pay a dividend – and how reliable is the payout?

**Dividend yield:** 1.5% (2025, estimated) **Dividend history:** Continuous payout over the last 5 years Laboratorios Farmaceuticos Rovi, S.A. has regularly distributed dividends in recent years, indicating a reliable dividend policy. The estimated dividend yield for 2025 is around 1.5%, which ca...

New support ticket

Explore

Laboratorios Farmaceuticos Rovi Stock Value

Laboratorios Farmaceuticos Rovi Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Laboratorios Farmaceuticos Rovi do?

Laboratorios Farmaceuticos Rovi Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Laboratorios Farmaceuticos Rovi Stock Value

Laboratorios Farmaceuticos Rovi Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Laboratorios Farmaceuticos Rovi do?

Laboratorios Farmaceuticos Rovi Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.